T45.1X4D
ICD-10-CMPoisoning by antineoplastic and immunosuppressive drugs, undetermined, subsequent encounter
This code signifies a patient presenting with adverse effects from antineoplastic (chemotherapy) or immunosuppressive medications, where the intent of the poisoning is not yet determined. This could involve an accidental overdose, an adverse drug reaction, or an intentional act, but the specific circumstances are still under investigation. The "subsequent encounter" indicates that the patient is receiving follow-up care for this poisoning after the initial treatment.
This code is appropriate for documenting ongoing management of a patient experiencing complications from antineoplastic or immunosuppressive drug exposure when the cause of the poisoning is unclear. This would include situations where the patient is admitted for monitoring, further diagnostic workup, or continued treatment of the toxic effects following an initial presentation. It's used after the acute phase of treatment has concluded and the patient is in a recovery or stabilization period.
AI-generated reference — verify against official guidelines
+5 more in this category